Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine with or without Cyclophosphamide in Previously Untreated CLL
NCT00003764Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Mar 2000
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of cyclophosphamide in chronic lymphocytic leukemia (CLL), sponsored by Eastern Cooperative Oncology Group. Started Mar 2000; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00003764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003764.